Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Buclin

Showing results (31-40 of 107) with videos related to

Pageof 11
Sort By:
Revue Medicale Suisse|February 23, 2010
[Pharmacovigilance update]F Livio, A Ivanyuk, J Biollaz, et al.
The American Journal of Physiology|June 1, 1995
Inhibition of Na(+)-K(+)-ATPase by digoxin and its relation with energy expenditure and nutrient oxidation rateX Lyon, Y Schutz, T Buclin, et al.
Lancet (London, England)|June 8, 1996
Safety of oral immunisation with recombinant urease in patients with Helicobacter pylori infectionC Kreiss, T Buclin, M Cosma, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|May 8, 2000
Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extractionC Marzolini, A Telenti, T Buclin, et al.
Revue Medicale Suisse|May 14, 2008
[Terbinafine induced hepatitis with persistent cholestasis]G Gendre, T Buclin, I Morard, et al.
Transplantation Proceedings|June 19, 2001
A preliminary evaluation of the discriminative power of the monoethylglycinexylidide formation test after intravenous and oral administration of lidocaineJ M Corpataux, A Munafo, T Buclin, et al.
Therapeutic Drug Monitoring|July 31, 2001
Nelfinavir plasma levels under twice-daily and three-times-daily regimens: high interpatient and low intrapatient variabilityC Marzolini, T Buclin, L A Decosterd, et al.
Early Human Development|October 2, 1995
Influence of perinatal, developmental and environmental factors on cognitive abilities of preterm children without major impairments at 5 yearsC L Fawer, S Besnier, M Forcada, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|October 29, 2000
Pharmacokinetics and pharmacodynamics of IFN-beta 1a in healthy volunteersP A Buchwalder, T Buclin, I Trinchard, et al.
Revue Medicale De La Suisse Romande|June 1, 1992
[Prognosis in brain stem infarction]C Exhenry, F Regli, J Bogousslavsky, et al.
Pageof 11

Showing results (31-40 of 107) with videos related to

Sort By:
Pageof 11
Revue Medicale Suisse|February 23, 2010
[Pharmacovigilance update]F Livio, A Ivanyuk, J Biollaz, et al.
The American Journal of Physiology|June 1, 1995
Inhibition of Na(+)-K(+)-ATPase by digoxin and its relation with energy expenditure and nutrient oxidation rateX Lyon, Y Schutz, T Buclin, et al.
Lancet (London, England)|June 8, 1996
Safety of oral immunisation with recombinant urease in patients with Helicobacter pylori infectionC Kreiss, T Buclin, M Cosma, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|May 8, 2000
Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extractionC Marzolini, A Telenti, T Buclin, et al.
Revue Medicale Suisse|May 14, 2008
[Terbinafine induced hepatitis with persistent cholestasis]G Gendre, T Buclin, I Morard, et al.
Transplantation Proceedings|June 19, 2001
A preliminary evaluation of the discriminative power of the monoethylglycinexylidide formation test after intravenous and oral administration of lidocaineJ M Corpataux, A Munafo, T Buclin, et al.
Therapeutic Drug Monitoring|July 31, 2001
Nelfinavir plasma levels under twice-daily and three-times-daily regimens: high interpatient and low intrapatient variabilityC Marzolini, T Buclin, L A Decosterd, et al.
Early Human Development|October 2, 1995
Influence of perinatal, developmental and environmental factors on cognitive abilities of preterm children without major impairments at 5 yearsC L Fawer, S Besnier, M Forcada, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|October 29, 2000
Pharmacokinetics and pharmacodynamics of IFN-beta 1a in healthy volunteersP A Buchwalder, T Buclin, I Trinchard, et al.
Revue Medicale De La Suisse Romande|June 1, 1992
[Prognosis in brain stem infarction]C Exhenry, F Regli, J Bogousslavsky, et al.
Pageof 11